(Hypertension. 1997;29:326.)
© 1997 American Heart Association, Inc.
Arthur C. Corcoran Memorial Lecture |
From the Medizinische Universitäts-Poliklinik, Bonn, Germany.
Correspondence to PD Dr A. Sachinidis, Medizinische Universitäts-Poliklinik, Wilhelmstr 3537, 53111 Bonn, Germany
In the present study, we describe possible mechanisms by which hypercholesterolemia may contribute to the development of cardiovascular diseases. Treatment of rat aortic smooth muscle cells for 20 hours with cholesterol-rich liposomes (500 µg/mL cholesterol, 100 µg/mL low-density lipoprotein) resulted in a 76±12% increase in total cholesterol content. The effects of cholesterol enrichment were examined by determination of changes in cell membrane fluidity. Fluidity of the cholesterol-enriched cell membranes was decreased at all temperatures between 15°C and 40°C. Changes in membrane fluidity in whole cell membranes represented changes in fluidity of microsomal membranes isolated by Percoll gradient ultracentrifugation. The basal [Ca2+]i and the maximal platelet-derived growth factor (PDGF)-BB-induced [Ca2+]i was elevated by 30% and 90% in cholesterol-enriched cells, respectively. In contrast, the resting pHi and the PDGF-BB-induced stimulation of the Na+/H+ exchange were not affected in cholesterol-enriched cells. The effect of PDGF-BB on [3H]thymidine incorporation in cholesterol-enriched cells was elevated by 40% in comparison with untreated cells. Our findings show that cellular cholesterol may be involved in the development of vascular diseases via modulation of the PDGF-induced increase in [Ca2+]i and DNA synthesis in vascular smooth muscle cells.
Key Words: cholesterol vascular smooth muscle cells platelet-derived growth factor
Abbreviations: DMEM = Dulbeccos modified Eagles medium PC = dipalmitoylphosphatidylcholine PDGF = platelet-derived growth factor VSMC = vascular smooth muscle cell(s)
This article has been cited by other articles:
![]() |
B. H. Rauch, G. A. Scholz, D. Baumgartel-Allekotte, P. Censarek, J. W. Fischer, A.-A. Weber, and K. Schror Cholesterol Enhances Thrombin-Induced Release of Fibroblast Growth Factor-2 in Human Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): e20 - e25. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. GOUNI-BERTHOLD and A. SACHINIDIS Does the coronary risk factor low density lipoprotein alter growth and signaling in vascular smooth muscle cells? FASEB J, October 1, 2002; 16(12): 1477 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sachinidis, R. Kettenhofen, S. Seewald, I. Gouni-Berthold, U. Schmitz, C. Seul, Y. Ko, and H. Vetter Evidence That Lipoproteins Are Carriers of Bioactive Factors Arterioscler. Thromb. Vasc. Biol., October 1, 1999; 19(10): 2412 - 2421. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sachinidis, S. Seewald, P. Epping, C. Seul, Y. Ko, and H. Vetter The Growth-Promoting Effect of Low-Density Lipoprotein May Be Mediated by a Pertussis Toxin-Sensitive Mitogen-Activated Protein Kinase Pathway Mol. Pharmacol., September 1, 1997; 52(3): 389 - 397. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |